← FDA Drug Approvals (Drugs@FDA)

HALAVEN

NDA · New Drug Application · Sponsor: EISAI INC · Approved 2010-11-15

Drug application

FDA Application #

NDA201532

Application type

New Drug Application

Brand name

HALAVEN

Generic name

ERIBULIN MESYLATE

Active ingredients

ERIBULIN MESYLATE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

EISAI INC

Manufacturer

BSP Pharmaceuticals SpA

First approval

2010-11-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown